TACE OR TAE FOR TREATMENT OF HEPATOCELLULAR CARCINOMA?

被引：0
|
作者：
Meredith, P. [1 ]
Kohler, K. [1 ]
Jeffries-Chung, C. [1 ]
See, T-C [2 ]
Griffiths, W. J. [1 ]
机构：
[1] Cambridge Univ Hosp, Dept Hepatol, Cambridge, England
[2] Cambridge Univ Hosp, Dept Radiol, Cambridge, England
来源：
GUT | 2012年 / 61卷
关键词：
D O I：
10.1136/gutjnl-2012-302514d.274
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A409 / A409
页数：1
相关论文
共 50 条
  • [21] Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out
    Bakopoulos, Anargyros
    Koliakos, Nikolaos
    Tsilimigras, Diamantis, I
    Schizas, Dimitrios
    Moris, Demetrios
    Angelopoulos, Argiris
    Spanakos, Spyridon
    Spartalis, Eleftherios
    Patapis, Pavlos
    Skandalakis, Panagiotis
    Troupis, Theodoros
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (13)
  • [22] Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment
    Larijani, Roshana Saghafian
    Ravari, Nazanin Shabani
    Goodarzi, Navid
    Akhlaghpour, Shahram
    Larijani, Samaneh Saghafian
    Rouini, Mohammad Reza
    Dinarvand, Rassoul
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 77
  • [23] CONCOMITANT VERSUS SEQUENTIAL TREATMENT WITH TACE AND SORAFENIB IN HEPATOCELLULAR CARCINOMA PATIENTS
    Sacco, R.
    Romano, A.
    Bargellini, I.
    Ginanni, B.
    Mismas, V.
    Vivaldi, C.
    Caparello, C.
    Musettini, G.
    Masi, G.
    Faggioni, L.
    Bresci, G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S403 - S403
  • [24] Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Lawson, Alexander
    Kamarajah, Sivesh K.
    Parente, Alessandro
    Pufal, Kamil
    Sundareyan, Ramanivas
    Pawlik, Timothy M.
    Ma, Yuk Ting
    Shah, Tahir
    Kharkhanis, Salil
    Dasari, Bobby V. M.
    CANCERS, 2023, 15 (12)
  • [25] TACE treatment in hepatocellular carcinoma: What should we do now?
    Farinati, Fabio
    Giacomin, Anna
    Vanin, Veronica
    Giannini, Edoardo
    Trevisani, Franco
    JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 221 - 222
  • [26] Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
    Chang, Pi-Yi
    Lee, Rheun-Chuan
    Liang, Po-Chin
    Liu, Yi-Sheng
    Chuang, Vicent P.
    Wu, Ding-Kwo
    Cheng, Yu-Fan
    Huang, Jen-I.
    Tseng, Hsiuo-Shan
    Hung, Chien-Fu
    Wu, Reng-Hong
    Chern, Ming-Chih
    Cheng, Hua-Ming
    Wu, Chih-Horng
    Cheng, She-Meng
    Chiang, Chia-Ling
    Liang, Huei-Lung
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma
    Zhu, Yuxia
    Feng, Bo
    Mei, Lin
    Sun, Ruiqing
    Guo, Changcun
    Zhu, Jiangyi
    JOURNAL OF BUON, 2019, 24 (02): : 608 - 614
  • [28] MORPHOPHENOTYPIC TACE PREDICTORS IN HEPATOCELLULAR CARCINOMA
    Sciarra, A.
    Di Tommaso, L.
    Ronot, M.
    Spagnuolo, G.
    Bedossa, P.
    Roncalli, M.
    Paradis, V.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S115 - S116
  • [29] The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)
    Hanks, B. A.
    Suhocki, P. V.
    DeLong, D. M.
    Doan, P. L.
    Liu, E.
    Tsai, A. L.
    Burke, C. T.
    Bernard, S. A.
    O'Neil, B. H.
    Morse, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Successful treatment of hepatocellular carcinoma (HCC) with transchateter arterial embolizazion (TAE) with microspheres (embosphere).
    Nicolini, A
    Sangiovanni, A
    Fasani, P
    Forzenigo, L
    Prati, GM
    Romeo, R
    Crespi, S
    Ronchi, G
    Biondetti, P
    Colombo, M
    HEPATOLOGY, 2005, 42 (04) : 391A - 392A
12345